Jorba-García, Adrià
González-Barnadas, Albert
Camps-Font, Octavi
Figueiredo, Rui http://orcid.org/0000-0002-2122-6530
Valmaseda-Castellón, Eduard
Article History
Received: 6 November 2020
Accepted: 5 February 2021
First Online: 26 February 2021
Declarations
:
: This article does not report on any studies with human participants or animals performed by any of the authors.
: For this type of study, formal consent is not required.
: The authors have no direct financial or other interests in the products or information mentioned in this paper. Adrià Jorba-Garcia and Albert González-Barnadas declare no conflicts of interest. Dr. Octavi Camps-Font reports grants from Avinent (Santpedor, Spain) and has participated as a sub-investigator in clinical trials sponsored by Mundipharma (Cambridge, UK) and Menarini Richerche (Florence, Italy).Dr. Rui Figueiredo reports grants, personal fees, and non-financial support from MozoGrau (Valladolid, Spain) and from Avinent (Santpedor, Spain) and personal fees from BioHorizons Iberica (Madrid, Spain), Inibsa Dental (Lliçà de Vall, Spain), Dentsply implants Iberia (Barcelona, Spain), and ADIN Implants (Afula, Israel) outside the submitted work. Dr. Figueiredo has also participated as a principal investigator in a randomized clinical trial sponsored by Mundipharma (Cambridge, UK) and in another clinical trial as a sub-investigator for Menarini Richerche (Florence, Italy). Dr. Eduard Valmaseda-Castellón reports personal fees and non-financial support from MozoGrau (Valladolid, Spain) and from Avinent (Santpedor, Spain) and personal fees from BioHorizons Iberica (Madrid, Spain), Inibsa Dental (Lliçà de Vall, Spain), and Dentsply implants Iberia (Barcelona, Spain) outside the submitted work. In addition, Dr. Valmaseda-Castellón has also participated as a sub-investigator in a randomized clinical trial sponsored by Mundipharma (Cambridge, UK).